<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="153035">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01903590</url>
  </required_header>
  <id_info>
    <org_study_id>ZTB-070713</org_study_id>
    <secondary_id>ZekaiTahirBurak-SCavkaytar1</secondary_id>
    <nct_id>NCT01903590</nct_id>
  </id_info>
  <brief_title>TVT Versus TOT in Urinary Stress Incontinence With No Intrinsic Sphincter Deficiency</brief_title>
  <official_title>PROSPECTIVE RANDOMIZED STUDY COMPARING TVT AND TOT IN FEMALE STRESS URINARY INCONTINENCE WITH NO INTRINSIC SPHINCTER DEFICIENCY</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zekai Tahir Burak Maternity and Teaching Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zekai Tahir Burak Maternity and Teaching Hospital</source>
  <oversight_info>
    <authority>Turkey: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to compare trans-vaginal tape(TVT) and trans-obturator tape(TOT)
      procedure in female urinary stress incontinence with no intrinsic sphincter deficiency.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with isolated stress incontinence attending to Dr Zekai Tahir Burak Woman Health
      Teaching and Research Hospital Urogynecology Department will be prospectively randomized,by
      a computer generated randomisation code,to the TVT or TOT. The patients will be  aware of
      the type of  the surgical procedure before the operation.

      Preoperative evaluation includes clinical history,urinanalysis,pelvic examination QoL
      assessment and urodynamic study. QoL included Urogenital Distress Inventory Short Form
      (UDI-6) and the Incontinence Impact Questionnaire Short Form( IIQ-7).Urodynamic study
      includes cystometry,urethral profilometry and Valsalva leak point pressure (VLPP).In all
      patients,pelvic floor defect will be evaluated according to the POP quantification (POPQ)
      staging.To diagnose the occult stress incontinence in patients with pelvic prolapse, a cough
      test after reducing the prolapse will be performed.Patients will be followed up at 6 and 12
      months postoperatively.Objective cure is defined as a negative cough stress test .Negative
      cough stress test ,but occasional urine leakage during stress will be considered
      ''improved''.

      Postoperative subjective outcomes will be  categorized as follows:cured (UDI-6 and IIQ-7
      postoperative&lt;10), improved (UDI-6 and IIQ-7  if postoperative&gt;preoperative)  and worsened
      (UDI-6 and IIQ-7 if postoperative&lt;preoperative).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">June 2014</completion_date>
  <primary_completion_date type="Anticipated">May 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Comparison of the efficiency of TVT and TOT in stress incontinence with no intrinsic deficiency</measure>
    <time_frame>One year</time_frame>
    <safety_issue>No</safety_issue>
    <description>Postoperative UDI-6 and IIQ-7 &lt;10 and negative cough test will be defined as ''cured''</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Objective effectiveness by cough test at 6 and 12 th months postoperatively</measure>
    <time_frame>One year</time_frame>
    <safety_issue>No</safety_issue>
    <description>A patient with a bladder filled 300 cc saline will cough and if no leakage of urine,the patient will be described as ''cured''.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective effectiveness by UDI-6 and IIQ-7 at 6-12 th months postoperatively</measure>
    <time_frame>One year</time_frame>
    <safety_issue>No</safety_issue>
    <description>Postoperative subjective outcomes will be  categorized as follows:cured (UDI-6 and IIQ-7 postoperative&lt;10), improved (UDI-6 and IIQ-7  if postoperative&gt;preoperative)  and worsened (UDI-6 and IIQ-7 if postoperative&lt;preoperative).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Short term and long term surgical complications</measure>
    <time_frame>One year</time_frame>
    <safety_issue>No</safety_issue>
    <description>Bleeding,bladder and bowel perforation,mesh erosion etc..</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The prevalence of voiding dysfunction at 1 and 12 th months postoperatively</measure>
    <time_frame>One year</time_frame>
    <safety_issue>No</safety_issue>
    <description>Postoperative residual volume after first voiding &gt;100 cc ,difficulty in voiding will be described as ''voiding dysfunction''.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Female Urinary Stress Incontinence</condition>
  <arm_group>
    <arm_group_label>Transvaginal Tape Surgery</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Randomized 50 patients undergoing TVT</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Transobturator tape surgery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Randomized 50 patients undergoing TOT</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>TVT surgery TOT surgery</intervention_name>
    <arm_group_label>Transvaginal Tape Surgery</arm_group_label>
    <arm_group_label>Transobturator tape surgery</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women with urinary stress incontinence with no intrinsic sphincter deficiency

          -  Women with or without pelvic organ prolapse

        Exclusion Criteria:

          -  Previous incontinence surgery

          -  Urge incontinence or overactive bladder

          -  Mixed incontinence

          -  Intrinsic sphincter deficiency

          -  Body mass index&gt;35

          -  Un-willing for randomisation
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sabri Cavkaytar, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zekai Tahir Burak Maternity and Teaching Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sabri Cavkaytar, MD</last_name>
    <email>sabri.cavkaytar@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Dr Zekai Tahir Burak Woman Health Teaching and Research Hospital</name>
      <address>
        <city>Ankara</city>
        <state>Cankaya</state>
        <zip>06590</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sabri Cavkaytar, MD</last_name>
      <phone>+905054526360</phone>
      <email>sabri.cavkaytar@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Seyfi Orhan Aksakal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mahmut Kuntay Kokanali, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hasan Onur Topcu, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Melike Doganay, Ass.Prof.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 2, 2014</lastchanged_date>
  <firstreceived_date>July 13, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Zekai Tahir Burak Maternity and Teaching Hospital</investigator_affiliation>
    <investigator_full_name>Sabri Cavkaytar</investigator_full_name>
    <investigator_title>Obstetrics and Gynecology specialist</investigator_title>
  </responsible_party>
  <keyword>TVT,TOT,Randomized</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Urinary Incontinence, Stress</mesh_term>
    <mesh_term>Urinary Incontinence</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
